Christine FitzGerald, MD, PhD

Director, Center for Healthy Elimination and Bladder Rehabilitation (CHEER); UroPediatrician, Department of Urology
Instructor in Surgery, Harvard Medical School
Image
Christine FitzGerald, MD, PhD

Christine FitzGerald, MD, PhD

Director, Center for Healthy Elimination and Bladder Rehabilitation (CHEER); UroPediatrician, Department of Urology
Instructor in Surgery, Harvard Medical School

Medical Services

Languages
English
Education
Undergraduate School
University of California Los Angeles
1987
Los Angeles
CA
Graduate School
University of Cincinnati
1997
Cincinnati
OH
Medical School
University of Cincinnati
1999
Cincinnati
OH
Residency
Pediatrics
Vanderbilt Medical Center
2003
Nashville
TN
Professional History

Christine FitzGerald, MD, PhD, provides nonsurgical care for children with common pediatric urology problems such as voiding dysfunction, recurrent urinary tract infections (UTIs), daytime accidents (enuresis), and bedwetting (nocturnal enuresis).

Dr. FitzGerald received her undergraduate degree from the University of California Los Angeles and her MD and PhD from the University of Cincinnati. She completed her pediatrics residency training at Vanderbilt Medical Center in Nashville, Tennessee. She worked as a general pediatrician in Southern New Hampshire for 19 years prior to joining Boston Children’s Department of Urology.

Dr. FitzGerald’s research focuses on nonsurgical urologic issues such as treatment of bedwetting, genetic causes of voiding dysfunction, and psychosocial processes affecting voiding dysfunction.

Approach to Care
As a general pediatrician I have had the privilege to care for many wonderful families over the years. As a parent myself, I have always felt that the most important aspects of that care involve listening and having compassion. As I bring my extensive pediatric experience to the field of urology, I hope to provide a comprehensive approach to voiding dysfunction in children and teens. I am also dedicated to research in this area so that we may better understand and treat these disorders.

Publications

Activated eIF4E-binding protein slows G1 progression and blocks transformation by c-myc without inhibiting cell growth. View Abstract